01/2024 FIRST PATIENTS ENROLLED IN THE GORE VBX FORWARD CLINICAL STUDY This study aims to compare the GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis primary patency to bare metal stenting to evaluate superiority in treating complex iliac occlusive disease with the goal of informing practice guidelines around which modality is best suited for patients with this condition. See more
08/2021 FIVE-YEAR RESULTS OF THE GORE® EXCLUDER® ILIAC BRANCH ENDOPROSTHESIS PIVOTAL U.S. MULTICENTER STUDY CONFIRM SAFETY, EFFICACY AND DURABILITY FLAGSTAFF, Ariz. (August 19, 2021) — W. L. Gore & Associates (Gore), today announced that five-year results of the U.S. prospective, multicenter study (N = 63) of endovascular repair of iliac aneurysms using the GORE® EXCLUDER® Iliac Branch Endoprosthesis (IBE) were presented at the 2021 Society for Vascular Surgery Annual Meeting. Results of the study confirmed the safety, efficacy and durability of the IBE for treatment of aortoiliac and iliac artery aneurysms. See more
08/2022 GORE ACQUIRES INNAVASC MEDICAL, INC. Gore, a global material science company dedicated to transforming industries and improving lives, announce the acquisition of InnAVasc Medical, Inc., a privately held medical technology company focused on advancing care for patients with end stage renal disease who utilize graft circuits for dialysis treatment. See more
12/2023 GORE ANNOUNCES FIRST PATIENT IMPLANT IN THE ARISE II PIVOTAL STUDY OF THE GORE® ASCENDING STENT GRAFT The first patient implant in the ARISE II Pivotal Study evaluation of the GORE® Ascending Stent Graft represents a major milestone in the development of endovascular treatment of the ascending aorta. See more
06/2023 GORE ANNOUNCES FIRST U.S. ENROLLMENT FOR THE GORE® VIAFORT VASCULAR STENT ILIOFEMORAL STUDY FIRST U.S. PATIENT ENROLLED IN GORE® VIAFORT VASCULAR STENT ILIOFEMORAL PIVOTAL STUDY See more
03/2023 GORE ANNOUNCES FIRST U.S. ENROLLMENT FOR THE GORE® VIAFORT VASCULAR STENT IVC STUDY First U.S. patient enrolled in GORE® VIAFORT Vascular Stent pivotal study. See more
04/2020 GORE Clinical Study Receives JVIR Editor’s Award For Outstanding Clinical Research Paper For 2019 From Journal of Vascular and Interventional Radiology W. L. Gore & Associates, Inc. (Gore) congratulates the REVISE research team for receiving the JVIR Editor’s Award for Outstanding Clinical Research Paper for 2019 from the Journal of Vascular and Interventional Radiology. See more
10/2022 Gore Completes First In-human Implants of the GORE® VIAFORT Vascular Stent FLAGSTAFF, Ariz. (October 28, 2022) — W. L. Gore & Associates (Gore) today announced the first implants of its investigational GORE® VIAFORT Vascular Stent as part of the recently initiated GORE VIAFORT Device Pivotal Clinical Study, (i.e., prospective, multicenter, non-randomized, single-arm study NCT05409976) for the treatment of inferior vena cava (IVC) occlusive disease with or without iliofemoral vein involvement. See more